These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26132834)

  • 1. Status of soluble ST2 levels in serum of HTLV-1 infected individuals.
    Zahedi Avval F; Shomali S; Nadri M; Boostani R; Jarahi L; Youssefi M
    Acta Microbiol Immunol Hung; 2015 Jun; 62(2):137-45. PubMed ID: 26132834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation.
    Houghton-Triviño N; Salgado DM; Rodríguez JA; Bosch I; Castellanos JE
    J Gen Virol; 2010 Mar; 91(Pt 3):697-706. PubMed ID: 19889931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The levels of soluble ST2 in sera and bullous fluid from patients with bullous pemphigoid.
    Wakatabi K; Komine M; Meephansan J; Matsuyama Y; Tsuda H; Tominaga S; Ohtsuki M
    Eur J Dermatol; 2012; 22(3):333-6. PubMed ID: 22494834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble ST2--analytical considerations.
    Mueller T; Jaffe AS
    Am J Cardiol; 2015 Apr; 115(7 Suppl):8B-21B. PubMed ID: 25697919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
    Pusceddu I; Dieplinger B; Mueller T
    Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of soluble ST2 in patients with active newly diagnosed ANCA-associated vasculitis.
    Hladinova Z; Hruskova Z; Svobodova B; Malickova K; Lanska V; Konopásek P; Jancova E; Rysava R; Edelstein CL; Tesar V
    Mediators Inflamm; 2015; 2015():603750. PubMed ID: 25802482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-33/ST2 correlates with severity of haemorrhagic fever with renal syndrome and regulates the inflammatory response in Hantaan virus-infected endothelial cells.
    Zhang Y; Zhang C; Zhuang R; Ma Y; Zhang Y; Yi J; Yang A; Jin B
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003514. PubMed ID: 25658420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ST2 Signaling in the Tumor Microenvironment.
    Chang CP; Hu MH; Hsiao YP; Wang YC
    Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced levels of interleukin 33 and increased levels of soluble ST2 in subjects with amyotrophic lateral sclerosis.
    Lin CY; Pfluger CM; Henderson RD; McCombe PA
    J Neuroimmunol; 2012 Aug; 249(1-2):93-5. PubMed ID: 22633272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 receptor-related protein ST2 and mitral valve repair outcome in patients with chronic degenerative mitral regurgitation.
    Galeone A; Lessana A; Mascolo E; Di Serio F; Marraudino N; Laborde F; Paparella D
    Thorac Cardiovasc Surg; 2014 Feb; 62(1):47-51. PubMed ID: 24065602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High plasma sST2 levels in gastric cancer and their association with metastatic disease.
    Bergis D; Kassis V; Radeke HH
    Cancer Biomark; 2016; 16(1):117-25. PubMed ID: 26835712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum soluble ST2 is associated with ER-positive breast cancer.
    Lu DP; Zhou XY; Yao LT; Liu CG; Ma W; Jin F; Wu YF
    BMC Cancer; 2014 Mar; 14():198. PubMed ID: 24636276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma--the Presage ST2 assay.
    Dieplinger B; Januzzi JL; Steinmair M; Gabriel C; Poelz W; Haltmayer M; Mueller T
    Clin Chim Acta; 2009 Nov; 409(1-2):33-40. PubMed ID: 19699192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble ST2 and IL-33: Potential markers of endometriosis in the Tunisian population.
    Mbarik M; Kaabachi W; Henidi B; Sassi FH; Hamzaoui K
    Immunol Lett; 2015 Jul; 166(1):1-5. PubMed ID: 25977120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased soluble ST2 and IL‑4 serum levels are associated with disease severity in patients with membranous nephropathy.
    Zhang Z; Liu X; Wang H; Qu Z; Crew R; Zhang N; Jiang Y
    Mol Med Rep; 2018 Feb; 17(2):2778-2786. PubMed ID: 29207152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus.
    Mok MY; Huang FP; Ip WK; Lo Y; Wong FY; Chan EY; Lam KF; Xu D
    Rheumatology (Oxford); 2010 Mar; 49(3):520-7. PubMed ID: 20026564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of reference intervals for soluble ST2 from a United States population.
    Lu J; Snider JV; Grenache DG
    Clin Chim Acta; 2010 Nov; 411(21-22):1825-6. PubMed ID: 20654603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal changes of soluble ST2 after cardiovascular interventions.
    Willems S; Sels JW; Flier S; Versteeg D; Buhre WF; de Kleijn DP; Hoefer IE; Pasterkamp G
    Eur J Clin Invest; 2013 Feb; 43(2):113-20. PubMed ID: 23215810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of IL-33 in immune thrombocytopenia.
    Li PP; Zhang XM; Yuan D; Liu X; Li Y; Shan NN
    Int Immunopharmacol; 2015 Sep; 28(1):420-4. PubMed ID: 26164496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.
    Ho JE; Chen WY; Chen MH; Larson MG; McCabe EL; Cheng S; Ghorbani A; Coglianese E; Emilsson V; Johnson AD; Walter S; Franceschini N; O'Donnell CJ; ; ; Dehghan A; Lu C; Levy D; Newton-Cheh C; ; Lin H; Felix JF; Schreiter ER; Vasan RS; Januzzi JL; Lee RT; Wang TJ
    J Clin Invest; 2013 Oct; 123(10):4208-18. PubMed ID: 23999434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.